1190028D05Rik activators comprise a diverse array of chemical compounds that engage various intracellular signaling mechanisms to enhance the functional activity of the protein encoded by the associated gene. Forskolin, Isoproterenol, Zaprinast, and Rolipram all serve to elevate intracellular cAMP, which in turn activates PKA, a kinase with the capacity to phosphorylate substrates that engage with 1190028D05Rik, thereby amplifying its activity. Ionomycin and A23187 function as calcium ionophores that raise intracellular calcium levels, activating calmodulin-dependent kinases which can subsequently enhance the activity of 1190028D05Rik through phosphorylation and alteration of calcium. 1190028D05Rik Activators are a diverse set of chemical compounds that indirectly stimulate the functional activity of 1190028D05Rik across various intracellular signaling pathways. Forskolin and IBMX both function by increasing intracellular cAMP, which subsequently activates PKA; this activation can lead to phosphorylation events that may enhance the functional capacity of 1190028D05Rik. Similarly, PMA, as a PKC activator, initiates a cascade of phosphorylation events that could facilitate the involvement of 1190028D05Rik in cellular functions.
Sodium orthovanadate and Epigallocatechin gallate operate through inhibition of protein tyrosine phosphatases and kinases, respectively, thus permitting increased tyrosine phosphorylation or altering kinase activity, which may favor the activation of pathways where 1190028D05Rik plays a role. LY294002 and PD98059 disrupt PI3K and MEK activities, respectively, which can reroute signaling to mechanisms involving1190028D05Rik Activators are a diverse set of chemical compounds that indirectly stimulate the functional activity of 1190028D05Rik across various intracellular signaling pathways. Forskolin and IBMX both function by increasing intracellular cAMP, which subsequently activates PKA; this activation can lead to phosphorylation events that may enhance the functional capacity of 1190028D05Rik. Similarly, PMA, as a PKC activator, initiates a cascade of phosphorylation events that could facilitate the involvement of 1190028D05Rik in cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium concentration. This activates calcium-dependent protein kinases that can modulate the activity of 1190028D05Rik, leading to its activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that elevates intracellular cAMP, thereby activating PKA. PKA activation can result in phosphorylation events that enhance the activity of 1190028D05Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and regulate proteins that are part of the pathway involving 1190028D05Rik, leading to its enhanced activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it can alter downstream signaling pathways, resulting in compensatory mechanisms that enhance the activity of 1190028D05Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that prevents the activation of MAPK/ERK. This alteration in MAPK signaling can shift cellular responses to enhance the activity of proteins like 1190028D05Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, which activates calcium-dependent enzymes and signaling pathways, potentially enhancing the activity of 1190028D05Rik. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, leading to increased cAMP levels within the cell. This elevation in cAMP can result in the activation of PKA and subsequent phosphorylation of proteins interacting with 1190028D05Rik. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, which leads to an increase in cAMP levels and activation of PKA. This cascade can enhance the phosphorylation and thus the activity of 1190028D05Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Inhibition of p38 may lead to the activation of alternative signaling pathways, which can include the phosphorylation and activation of proteins in the 1190028D05Rik pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor. By inhibiting ROCK, it can lead to changes in cytoskeletal dynamics that are known to affect signaling pathways, potentially leading to the enhanced activity of proteins like 1190028D05Rik. | ||||||